| Literature DB >> 35684056 |
Benjamin Boecking1, Sven Klasing1, Michael Walter2, Petra Brueggemann1, Amarjargal Nyamaa1, Matthias Rose3, Birgit Mazurek1.
Abstract
Little is known about molecular correlates of chronic tinnitus. We examined interrelationships between vascular-metabolic risk factors, perceived stress, and other routine blood values in patients with chronic tinnitus. Two-hundred patients (51% female) were screened for 49 blood parameters pertaining to vascular-metabolic risk, immune function, and redox processes. They further completed perceived stress- and tinnitus-related distress questionnaires. Following descriptive analyses, gender-specific sets of age- and tinnitus-severity-adjusted regression models investigated associations between perceived stress and blood parameters. Patients reported mildly elevated levels of perceived stress. Elevated levels of total cholesterol (65% and 61% of female and male patients, respectively), non-HDL-c (43/50%), LDL-c (56/59%), and lipoprotein_a (28/14%) were accompanied by high rates of overweight (99/100%) and smoking (28/31%). A low-level inflammatory state was accompanied by reduced reactive oxygen species (ROS)-neutralizing capacity (reduced co-enzyme Q10 and SOD1 levels). Most vascular risk factors were not correlated with perceived stress, except for fibrinogen (ß = -0.34) as well as C-reactive protein (ß = -0.31, p < 0.05) in men, and MCV (ß = -0.26, p < 0.05) in women. Interrelations between blood parameters and stress levels need to be investigated within psychobehavioural frameworks across varying distress levels. Alongside psychological interventions, a low-level inflammatory state may be a route for pharmacological therapeutics.Entities:
Keywords: biomarkers; blood parameters; chronic tinnitus; perceived stress; vascular–metabolic risk
Mesh:
Year: 2022 PMID: 35684056 PMCID: PMC9183085 DOI: 10.3390/nu14112256
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Sociodemographic data and patient characteristics (n = 169).
|
| % | |
|---|---|---|
| Nationality | ||
| German | 158 | 79.0 |
| Other | 11 | 5.5 |
| Education | ||
| Completed junior apprenticeship | 44 | 22.0 |
| Completed senior apprenticeship | 28 | 14.0 |
| University degree | 90 | 45.0 |
| Employment ‘yes’ | 119 | 59.5 |
| Relationship status | ||
| Single | 31 | 15.5 |
| Married | 114 | 57.0 |
| Divorced | 16 | 8.0 |
| Widowed | 7 | 3.5 |
| Duration of tinnitus | ||
| <0.5 year | 21 | 10.5 |
| 0.5–1 year | 25 | 12.5 |
| 1–2 years | 12 | 6.0 |
| 2–5 years | 31 | 15.5 |
| >5 years | 66 | 33.0 |
| Past psychotherapy ‘yes’ | 86 | 43.0 |
Means and standard deviations for the psychological indices.
| Total | Women | Men | ||||
|---|---|---|---|---|---|---|
| Mean |
| Mean |
| Mean |
| |
| PSQ total | 50.27 | 13.19 | 51.44 | 12.16 | 49.07 | 14.16 |
| Worries | 13.62 | 9.32 | 13.79 | 10.04 | 13.44 | 8.56 |
| Tension | 19.14 | 16.50 | 19.99 | 18.03 | 18.26 | 14.79 |
| Joy * | 16.80 | 15.67 | 15.89 | 13.31 | 17.74 | 17.83 |
| Demands | 17.08 | 14.55 | 17.46 | 15.33 | 16.70 | 13.76 |
| TQ total | 43.80 | 19.01 | 45.29 | 18.27 | 42.26 | 19.72 |
* Reversely coded (i.e., the higher the better). PSQ = Perceived Stress Questionnaire; TQ = Tinnitus Questionnaire (German version).
Means and standard deviations of vascular–metabolic risk factors and frequency rates of blood parameters with increased or decreased incidence rates of ≥25%. Relevant indices are highlighted for emphasis.
| Total | Women | Men | |||||
|---|---|---|---|---|---|---|---|
| Unit | Mean |
| Mean |
| Mean |
| |
| § Weight | kg | 78.86 | 15.71 | 78.59 | 16.04 | 79.12 | 15.50 |
| § BMI | kg/m2 | 26.32 | 4.44 | 25.94 | 4.70 | 26.70 | 4.17 |
| Frequency | % (total) | Frequency | % (women) | Frequency | % (men) | ||
| † Current smoking | ‘yes‘ | 59 | 45.4 | 33 | 50.8 | 26 | 40.0 |
| †§ Regular drinking | ‘yes‘ | 29 | 22.3 | 14 | 21.5 | 15 | 23.1 |
§ These risk factors were only available for a subset of n = 128 patients (65% of total sample; n = 65 women; n = 63 men).† Operationalized as drinking regularly “at least weekly”. BMI = Body Mass Index (underweight: <18.5; normal: 18.5–25; overweight: 25–30; obese: >30).
Frequency rates of participants with increased or decreased vascular-metabolic blood parameters. Indices with ‘outstanding’ rates of ≥ 25% are highlighted for emphasis.
| Unit | Mean |
| Reference Values | Frequency Decreased | Frequency Increased | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Total | (% Total) | Women | (% Women) | Men | (% Men) | Total | (% Total) | Women | (% Women) | Men | (% Men) | ||||
|
| mg/dL | 212.31 | 38.24 | <200 | <200 | - | - | - | - | - | - | 126 |
| 66 |
| 60 |
|
| Triglycerides | mg/dL | 124.25 | 62.24 | ≤200 | ≤200 | - | - | - | - | - | - | 23 | (11.5) | 7 | (6.9) | 16 | (16.3) |
| HDL-c | mg/dL | 63.23 | 18.34 | ≥35 | ≥45 | 6 | (3) | 3 | (2.9) | 3 | (3.1) | - | - | - | - | - | - |
|
| mg/dL | 149.34 | 39.75 | <150 | <150 | - | - | - | - | - | - | 93 |
| 44 |
| 49 |
|
|
| mg/dL | 137.10 | 34.56 | <130 | <130 | - | - | - | - | - | - | 115 |
| 57 |
| 58 |
|
|
| nmol/L | 45.83 | 65.34 | <72.0 | <72.0 | - | - | - | - | - | - | 42 | (21.0) | 28 |
| 14 | (14.3) |
HDL-c = high-density lipoprotein; LDL-c = low-density lipoprotein; non-HDL-c = non-high-density lipoprotein.
Means, standard deviations, reference values, and frequency rates of participants with increased or decreased non-vascular-metabolic blood parameters. Indices with ‘outstanding’ rates of ≥25% are highlighted for emphasis.
| Unit | Mean |
| Reference Values | Frequency Decreased | Frequency Increased | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Total | % Total | Women | % Women | Men | % Men | Total | % Total | Women | % Women | Men | % Men | ||||
| Leukocytes | nL | 6.58 | 1.58 | 3.9–10.5 | 3.9–10.5 | 6 | (3) | 3 | (2.9) | 3 | (3.1) | 2 | (1.0) | - | - | 2 | (2.0) |
| Lymphocytes | absolute/nL | 1.96 | 0.56 | 1.10–4.50 | 1.10–4.50 | 8 | (4) | 5 | (4.9) | 3 | (3.1) | 2 | (1.0) | - | - | - | - |
| Lymphocytes | % | 30.43 | 7.76 | 20.0–44.0 | 20.0–44.0 | 17 | (8.5) | 9 | (8.8) | 8 | (8.2) | 12 | (6.0) | 9 | (8.8) | 3 | (3.1) |
| Monocytes | absolute/nL | 0.52 | 0.16 | 0.10–0.90 | 0.10–0.90 | - | - | - | - | - | - | 6 | (3.0) | 1 | (1.0) | 5 | (5.1) |
|
| % | 7.94 | 1.92 | 2.0–9.5 | 2.0–9.5 | - | - | - | - | - | - | 35 | (17.5) | 11 | (10.8) | 24 |
|
| Neutrophils | absolute/nL | 3.87 | 1.20 | 1.50–7.70 | 1.50–7.70 | 1 | (0.5) | 1 | (1.0) | - | - | - | - | - | - | - | - |
| Neutrophils | % | 58.35 | 8.74 | 42.0–77.0 | 42.0–77.0 | 9 | (4.5) | 6 | (5.9) | 3 | (3.1) | 5 | (2.5) | 4 | (3.9) | 1 | (1.0) |
| NLR | cells/μL | 2.10 | 0.86 | 1–3 * | 1–3 * | - | - | - | - | - | - | - | - | - | - | - | - |
| Immature_granulocytes | absolute/nL | 0.02 | 0.02 | <0.050 | <0.050 | - | - | - | - | - | - | 11 | (5.5) | 1 | (1.0) | 10 | (10.2) |
| Immature_granulocytes | % | 0.36 | 0.20 | 0.0–1.0 | 0.0–1.0 | - | - | - | - | - | - | 4 | (2.0) | - | - | 4 | (4.1) |
| Eosinophils | absolute/nL | 0.14 | 0.10 | 0.02–0.50 | 0.02–0.50 | 3 | (1.5) | 1 | (1.0) | 2 | (2.0) | 1 | (0.5) | - | - | 1 | (1.0) |
| Eosinophils | % | 2.07 | 1.32 | 0.5–5.5 | 0.5–5.5 | 11 | (5.5) | 8 | (7.8) | 3 | (3.1) | 6 | (3.0) | 3 | (2.9) | 3 | (3.1) |
| Basophils | absolute/nL | 0.05 | 0.02 | 0.00–0.20 | 0.00–0.20 | - | - | - | - | - | - | - | - | - | - | - | - |
| Basophils | % | 0.74 | 0.32 | 0.0–1.8 | 0.0–1.8 | - | - | - | - | - | - | - | - | - | - | - | - |
| TNF-α | pg/mL | 0.32 | 0.05 | <8.1 | <8.1 | - | - | - | - | - | - | - | - | - | - | - | - |
| IL6 | ng/L | 1.83 | 1.12 | ≤7.0 | ≤7.0 | - | - | - | - | - | - | 3 | (1.5) | 1 | (1.0) | 2 | (2.0) |
| CRP | mg/L | 1.61 | 1.72 | <5.0 | <5.0 | - | - | - | - | - | - | 10 | (5.0) | 7 | (6.9) | 3 | (3.1) |
| Fibrinogen | g/L | 2.72 | 0.57 | 1.60–4.00 | 1.60–4.00 | 4 | (2) | 4 | (3.9) | - | - | 3 | (1.5) | 2 | (2.0) | 1 | (1.0) |
| Ferritin | qg/L | 128.29 | 93.09 | 30.0–400.0 | 13.0–150.0 | 4 | (2.0) | 2 | (2.0) | 2 | (2.0) | 19 | (9.5) | 14 | (13.7) | 5 | (5.1) |
| Thrombocytes | nL | 244.33 | 54.29 | 150–370 | 150–370 | 1 | (0.5) | - | - | 1 | (1.0) | 5 | (2.5) | 4 | (3.9) | 1 | (1.0) |
| MPV | fl | 10.68 | 1.00 | 7.0–12.0 | 7.0–12.0 | - | - | - | - | - | - | 19 | (9.5) | 7 | (6.9) | 12 | (12.2) |
| Hemoglobin | g/dL | 14.40 | 1.24 | 13.5–17.0 | 12.0–15.6 | 5 | (2.5) | 2 | (2.0) | 3 | (3.1) | 5 | (2.5) | - | - | 5 | (5.1) |
| Hematocrit | l/L | 0.43 | 0.04 | 0.395–0.505 | 0.355–0.455 | 6 | (3.0) | 3 | (2.9) | 3 | (3.1) | 6 | (3.0) | 3 | (2.9) | 3 | (3.1) |
| Erythrocytes | pl | 4.82 | 0.43 | 4.3–5.8 | 3.9–5.2 | 1 | (0.5) | - | - | 1 | (1.0) | 5 | (2.5) | - | - | 5 | (5.1) |
| MCV | fl | 88.33 | 3.60 | 80.0–99.0 | 80.0–99.0 | 2 | (1.0) | 1 | (1.0) | 1 | (1.0) | - | - | - | - | - | - |
| RDW_CV | % | 12.79 | 0.58 | 11.5–15.0 | 11.5–15.0 | - | - | - | - | - | - | - | - | - | - | - | - |
| MCH | pg | 29.89 | 1.27 | 27.0–33.5 | 27.0–33.5 | 3 | (1.5) | 2 | (2.0) | 1 | (1.0) | - | - | - | - | - | - |
| MCHC | g/dL | 33.83 | 0.94 | 31.5–36.0 | 31.5–36.0 | 5 | (2.5) | 4 | (3.9) | 1 | (1.0) | 3 | (1.5) | 1 | (1.0) | 2 | (2.0) |
|
| ng/mL | 63.89 | 4.53 | 77–531 | 77–531 | 190 |
| 100 |
| 90 |
| - | - | - | - | - | - |
| Superoxide–Dismutase 2 | ng/mL | 58.93 | 15.52 | >40 | >40 | 16 | (8.0) | 16 | (15.7) | - | - | - | - | - | - | - | - |
| Lipid_Peroxidase | μmol/L | 64.10 | 79.66 | <200 | <200 | - | - | - | - | - | - | 11 | (5.5) | 10 | (9.8) | 1 | (1.0) |
|
| μmol/mmol | 0.23 | 0.07 | >0.2 | >0.2 | 77 |
| 44 |
| 33 |
| - | - | - | - | - | - |
| Albumin | g/L | 46.36 | 2.50 | 35.0–52.0 | 35.0–52.0 | - | - | - | - | - | - | 3 | (1.5) | - | - | 3 | (3.1) |
| GOT | U/L | 24.84 | 6.46 | <50 | <35 | - | - | - | - | - | - | 4 | (2.0) | 2 | (2.0) | 2 | (2.0) |
| GPT | U/L | 27.92 | 12.22 | <41 | <31 | - | - | - | - | - | - | 38 | (19.0) | 15 | (14.7) | 23 | (23.5) |
| Gamma_GT | U/L | 24.64 | 13.29 | 8–61 | 5–36 | - | - | - | - | - | - | 12 | (6.0) | 9 | (8.8) | 3 | (3.1) |
|
| mL/min | 84.43 | 8.46 | >90 | >90 | 101 |
| 51 |
| 50 |
| - | - | - | - | - | - |
| Uric acid | mg/dL | 4.93 | 1.23 | 3.6–8.2 | 2.3–6.1 | 1 | (0.5) | - | - | 1 | (1.0) | 5 | (2.5) | 3 | (2.9) | 2 | (2.0) |
| Creatinine | mg/dL | 0.85 | 0.15 | 0.70–1.20 | 0.50–0.90 | 1 | (0.5) | 1 | (1.0) | - | - | 1 | (0.5) | 1 | (1.0) | - | - |
| Calcium | mmol/L | 2.34 | 0.09 | 2.15–2.50 | 2.15–2.50 | 5 | (2.5) | 3 | (2.9) | 2 | (2.0) | - | - | - | - | - | - |
| Magnesium | mmol/L | 0.85 | 0.05 | 0.66–1.07 | 0.66–1.07 | - | - | - | - | - | - | - | - | - | - | - | - |
|
| qmol/L | 12.63 | 1.77 | 12.0–26.0 | 9.0–22.0 | 31 | (15.5) | 1 | (1.0) | 30 |
| - | - | - | - | - | - |
| Selenium | qmol/L | 1.00 | 0.21 | 0.60–1.50 | 0.60–1.50 | 4 | (2.0) | 2 | (2.0) | 2 | (2.0) | 4 | (2.0) | 3 | (2.9) | 1 | (1.0) |
| Vitamin D3 | nmol/L | 65.30 | 21.02 | 50.0–150.0 | 50.0–150.0 | 46 | (23.0) | 24 | (23.5) | 22 | (22.4) | - | - | - | - | - | - |
CRP = C-reactive_protein; GFR = glomerular filtration rate; GOT = glutamate–oxalacetate–transaminase; GPT = glutamate–pyruvate–transaminase; IL6 = interleukin-6; MCH = mean corpuscular/cellular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; MCV = mean corpuscular/cell volume; MPV = mean platelet volume; NLR = neutrophil/lymphocyte ratio; RDW_CV = red blood cell distribution width; TNF-α = tumor necrosis factor alpha; * reference value obtained from www.mdcalc.com/neutrophil-lymphocyte-ratio-nlr-calculator#pearls-pitfalls (accessed on 2 April 2022).
Age- and tinnitus-related distress-adjusted univariate regression analyses with perceived stress indices being regressed on blood parameter values for the total sample, female patients, and male patients with chronic tinnitus. Only significant associations are reported (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Vascular risk markers | Lipoprotein_a | 0.14 | 1.99 * | ||||||||
| Inflammatory markers | CRP | −0.19 | −2.12 * | −0.15 | −2.10 * | ||||||
| Fibrinogen | −0.16 | −2.36 * | |||||||||
| Ferritin | −0.19 | −2.11 * | |||||||||
| MCV | 0.29 | 4.27 *** | 0.25 | 3.58 *** | 0.25 | 3.40 ** | 0.27 | 3.96 *** | |||
| MCHC | −0.23 | −3.27 ** | −0.20 | 2.84 ** | −0.20 | −2.59 * | −0.21 | −2.96 ** | |||
| Oxidative stress markers | Ubiquinone(Q10)_lipid-corrected | −0.15 | −2.08 * | −0.22 | −3.14 ** | −0.22 | −3.09 ** | ||||
| Selenium | 0.17 | 2.29 * | |||||||||
| Magnesium | 0.15 | 2.10 * | |||||||||
| Zinc | 0.27 | 3.78 *** | 0.25 | 3.52 ** | 0.22 | 2.85 ** | 0.24 | 3.40 ** | |||
| Cellular immune reponse | Basophils (abs) | 0.17 | 2.35 * | ||||||||
| Basophils (%) | 0.16 | 2.25 * | 0.18 | 2.52 * | |||||||
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Vascular risk markers | Lipoprotein_a | 0.21 | 1.98 * | ||||||||
| Inflammatory markers | Ferritin | 0.25 | 2.50 * | 0.27 | 2.86 ** | 0.21 | 2.18 * | 0.22 | 2.28 * | ||
| MCV | 0.26 | 2.06 * | 0.36 | 3.64 *** | 0.29 | 3.01 ** | 0.21 | 2.05 * | 0.34 | 3.57 ** | |
| MCHC | −0.24 | −2.30 * | −0.21 | −2.12 * | |||||||
| Hematocrit | 0.22 | 2.19 * | 0.28 | 2.91 ** | 0.29 | 2.95 ** | 0.30 | 3.20 ** | |||
| Hemoglobin | 0.24 | 2.42 * | 0.24 | 2.43 * | 0.24 | 2.44 * | |||||
| RDW_CV | −0.21 | −2.13 * | −0.20 | −1.99 * | |||||||
| Oxidative stress markers | Selenium | 0.21 | 2.12 * | ||||||||
| Magnesium | 0.22 | 2.23 * | 0.20 | 2.07 * | |||||||
| Zinc | 0.34 | 3.35 ** | 0.32 | 3.23 ** | 0.22 | 2.17 * | 0.33 | 3.39 ** | |||
| SOD-2 | 0.22 | 2.16 * | 0.21 | 2.19 * | 0.20 | 2.07 * | |||||
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Inflammatory markers | CRP | −0.31 | −2.35 * | ||||||||
| Fibrinogen | −0.34 | −2.63 * | −0.28 | −2.84 ** | −0.26 | −2.60 * | |||||
| Ferritin | −0.26 | −2.54 * | |||||||||
| MCV | 0.23 | −2.32 * | 0.29 | 2.69 ** | |||||||
| MCHC | −0.24 | 2.34 * | −0.23 | −2.32 * | −0.24 | −2.16 * | |||||
| IL-6 | 0.31 | 2.87 ** | |||||||||
| Uric acid | −0.24 | −2.33 * | −0.28 | 2.74 ** | |||||||
| Oxidative stress markers | Ubiquinone(Q10)_lipid-corrected | −0.24 | −2.43 * | −0.24 | −2.71 ** | ||||||
| Selenium | 0.30 | 2.23 * | |||||||||
| Immunological markers | Basophils (abs) | 0.22 | 2.13 * | 0.20 | 1.98 * | ||||||
| Basophils (%) | 0.38 | 2.91 ** | 0.35 | 3.53 ** | 0.27 | 2.77 ** | 0.27 | 2.68 ** | |||
| Leukocytes | −0.21 | −2.03 * | |||||||||
| Neutrophils (abs) | −0.24 | −2.32 * | |||||||||
| Neutrophils (%) | −0.22 | −2.17 * | |||||||||
| Liver function | GPT | −0.28 | −2.11 * |
CRP = C-reactive protein; MCV = mean corpuscular/cell volume; MCHC = mean corpuscular hemoglobin concentration; PSQ = Perceived Stress Questionnaire; RDW_CV = red blood cell distribution width; SOD-2 = Superoxide Dismutase 2; GPT = glutamate–pyruvate–transaminase; IL-6 = interleukin-6.